Process flow diagram

Vision Energy Engineering Progress Report

Retrieved on: 
Wednesday, January 25, 2023

JERSEY CITY, N.J., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Vision Energy Corporation (OTCPINK:VENG) (“Vision Energy” or the “Company”) is pleased to provide an update to the engineering and design advancements for its Energy Hub development in North Sea Port of Vlissingen, the Netherlands.

Key Points: 
  • JERSEY CITY, N.J., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Vision Energy Corporation (OTCPINK:VENG) (“Vision Energy” or the “Company”) is pleased to provide an update to the engineering and design advancements for its Energy Hub development in North Sea Port of Vlissingen, the Netherlands.
  • The Company’s wholly owned subsidiary, Evolution Terminals BV, has received an initial delivery of a series of engineering materials under the scope and deliverables for the preliminary Front End Engineering and Design (“pre-FEED”) study that was initiated by the Company through the engagement of Linde Engineering in November 2022.
  • All Ammonia infrastructure is designed to be compatible with LPG for commercial flexibility.
  • The Company is executing on its strategy to parallel-track engineering design and development with permitting efforts to ensure continued progress to FID, which is anticipated by Q4 2023.

Medaro to Obtain Independent Third-Party Review of Technology Engages Engineering Firm for Pilot Plant Process Diagrams

Retrieved on: 
Monday, November 14, 2022

Medaro has engaged Materials and Chemistry Laboratory (MCLinc) to validate the chemical reactions in the Technology.

Key Points: 
  • Medaro has engaged Materials and Chemistry Laboratory (MCLinc) to validate the chemical reactions in the Technology.
  • MCLinc provides expert consultation and specialty laboratory analyses in support of industrial forensics, materials characterization, environmental chemistry, uranium chemistry, mercury studies, carbon fiber, nanoparticles technology and process optimization.
  • Medaro has also engaged Process Engineering International, LLC (PROCESS) to assist in the preparation of a Process Flow Diagram (a PFD) for the pilot plant.
  • Having MCLinc perform an independent third-party review will further instill the confidence we have in the Technology, while working alongside PROCESS will ensure we get off on the right foot during this planning phase of our pilot plant.

The Worldwide Pharmacovigilance Industry is Expected to Reach $15.8 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 9, 2022

The global pharmacovigilance market size is expected to reach USD 15.84 Billion by 2030 according to a new study.

Key Points: 
  • The global pharmacovigilance market size is expected to reach USD 15.84 Billion by 2030 according to a new study.
  • The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
  • Moreover, the pharmaceutical sector's excessive expenditure, rising incidence of adverse drug events, and drug mistakes are propelling the industry forward.
  • Furthermore, the coronavirus pandemic has produced an emergency demand for a vaccine that has offered several chances for industry participants.

World Pharmacovigilance Market Size, Share & Trends, Analysis & Forecast Report 2022-2030: Increasing Externalization of Clinical Trial Studies by Large Pharmaceutical and Biopharmaceutical Companies - ResearchAndMarkets.com

Retrieved on: 
Friday, January 21, 2022

ADR imposes a substantial burden on healthcare systems and is one of the prominent causes of morbidity in developed countries.

Key Points: 
  • ADR imposes a substantial burden on healthcare systems and is one of the prominent causes of morbidity in developed countries.
  • According to the National Center for Biotechnology Information (NCBI), approximately 5% of total hospitalizations in Europe each year are due to ADR.
  • Pharmacovigilance services play an integral role in this clinical trial phase by assisting manufacturers in identifying adverse effects associated with the drug.
  • For instance, in December 2020, ArisGlobal and EVERSANA declared a strategic partnership to digitally transform end-to-end pharmacovigilance services globally.

Global Pharmacovigilance Markets Analysis & Forecasts 2016-2020 & 2021-2026 by Clinical Trial Phase, Method, Service Provider, Process Flow, Therapeutic Area, End-User - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 27, 2021

Keeping in view the chances of Adverse Drug Reactions (ADR) and drug toxicity, healthcare companies are continuously incorporating pharmacovigilance services.

Key Points: 
  • Keeping in view the chances of Adverse Drug Reactions (ADR) and drug toxicity, healthcare companies are continuously incorporating pharmacovigilance services.
  • Global pharmacovigilance market can be segmented based on clinical trial phase, method, service provider, end-user and region.
  • To forecast global pharmacovigilance market based on clinical trial phase, method, service provider, end-user, company and regional distribution.
  • To identify and analyze the profile of leading players operating in the global pharmacovigilance market.

U.K. Pharmacovigilance Market 2021-2028: Spontaneous Reporting Holds Largest Share - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 20, 2021

Moreover, the introduction of technologically advanced and user-friendly software systems, such as cloud-based PV platforms, is anticipated to drive the market in the coming years.

Key Points: 
  • Moreover, the introduction of technologically advanced and user-friendly software systems, such as cloud-based PV platforms, is anticipated to drive the market in the coming years.
  • In June 2017, Genpact launched Pharmacovigilance Artificial Intelligence ("PVAI") solution to alter drug safety data management and reporting.
  • An increase in R&D and the adoption of new technologies in clinical research are likely to further drive the market.
  • Some of the data management software include PV-Works Human, ClinSource, and Oracle
    The oncology therapeutic area segment held the largest share of over 25.0% in 2020.

Infogix Completes 3D Lineage Vision in Data360, Connecting Critical Data to Business Processes and Operations

Retrieved on: 
Thursday, October 1, 2020

The Process Diagram follows the release of Data360's automated Data Lineage Diagrams and business-outcome focused Business Impact Diagrams, providing a 360 view of business knowledge around enterprise data.

Key Points: 
  • The Process Diagram follows the release of Data360's automated Data Lineage Diagrams and business-outcome focused Business Impact Diagrams, providing a 360 view of business knowledge around enterprise data.
  • "3D Lineage Process Diagrams connect business processes to the underlying data assets, giving data leaders a critical tool to make more informed data decisions, improve business operations and increase overall program value."
  • 3D Lineage Process Diagrams complement Data360's ability to provide data reconciliation, workflow and case management by implementing a process-focused system and aligning business processes to business rules and data."
  • To learn more about Infogix's 3D Lineage for Data360 and how to streamline business processes with data, please visit http://www.infogix.com or @infogix.